Welcome to LookChem.com Sign In|Join Free

CAS

  • or

139025-93-7

Post Buying Request

139025-93-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

139025-93-7 Usage

Description

4-Morpholinocyclohexanone is an organic compound that serves as a valuable synthetic intermediate in the chemical industry. It is characterized by the presence of a morpholine ring and a cyclohexanone group, which contribute to its unique chemical properties and reactivity.

Uses

Used in Pharmaceutical Industry:
4-Morpholinocyclohexanone is used as a synthetic intermediate for the production of various pharmaceutical compounds. Its unique structure allows for the creation of complex molecules with potential therapeutic applications.
Used in Chemical Synthesis:
In the field of chemical synthesis, 4-morpholinocyclohexanone is utilized as a key building block for the development of novel organic compounds. Its versatility in reactions enables the synthesis of a wide range of products, including those with potential applications in various industries.
Used in Research and Development:
4-Morpholinocyclohexanone is also employed in research and development settings, where it is used to explore new reaction pathways and develop innovative synthetic methods. Its unique properties make it an attractive candidate for studying various aspects of organic chemistry and chemical biology.
For example, the provided materials mention that 4-morpholinocyclohexanone was used to synthesize diastereomeric 3,6-diaminobicyclo[3.1.0]hexane derivatives, showcasing its application in the synthesis of complex organic molecules with potential uses in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 139025-93-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,9,0,2 and 5 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 139025-93:
(8*1)+(7*3)+(6*9)+(5*0)+(4*2)+(3*5)+(2*9)+(1*3)=127
127 % 10 = 7
So 139025-93-7 is a valid CAS Registry Number.

139025-93-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-morpholin-4-ylcyclohexan-1-one

1.2 Other means of identification

Product number -
Other names 4-(morpholin-4-yl)cyclohexan-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:139025-93-7 SDS

139025-93-7Relevant articles and documents

Cobalt-Catalyzed Desymmetric Isomerization of Exocyclic Olefins

Lan, Yu,Liu, Qiang,Liu, Shihan,Liu, Xufang,Rong, Xianle

supporting information, p. 20633 - 20639 (2021/12/17)

Chiral cyclic olefins, 1-methylcyclohexenes, are versatile building blocks for the synthesis of pharmaceuticals and natural products. Despite the prevalence of these structural motifs, the development of efficient synthetic methods remains an unmet challenge. Herein we report a novel desymmetric isomerization of exocyclic olefins using a series of newly designed chiral cobalt catalysts, which enables a straightforward construction of chiral 1-methylcyclohexenes with diversified functionalities. The synthetic utility of this methodology is highlighted by a concise and enantioselective synthesis of a natural product, β-bisabolene. The versatility of the reaction products is further demonstrated by multifarious derivatizations.

COMPOUNDS

-

Page/Page column 105, (2018/08/30)

Provided are novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, compositions containing them and their use in the treatment of or prevention of diseases associated with or characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).

THE USE OF 7-AZAINDOLES IN THE INHIBITION OF C-JUN N-TERMINAL KINASE

-

Page/Page column 175-176, (2008/12/08)

The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 139025-93-7